-
1 Comment
Nanjing Well Pharmaceutical Group Co.,Ltd is currently in a long term downtrend where the price is trading 10.9% below its 200 day moving average.
From a valuation standpoint, the stock is 58.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.0.
Nanjing Well Pharmaceutical Group Co.,Ltd's total revenue sank by 19.6% to $179M since the same quarter in the previous year.
Its net income has dropped by 46.4% to $18M since the same quarter in the previous year.
Finally, its free cash flow fell by 492.2% to $-73M since the same quarter in the previous year.
Based on the above factors, Nanjing Well Pharmaceutical Group Co.,Ltd gets an overall score of 1/5.
| Sector | Healthcare |
|---|---|
| Industry | Drug Manufacturers - Specialty & Generic |
| Exchange | SHG |
| CurrencyCode | CNY |
| ISIN | CNE100003JD4 |
| Target Price | None |
|---|---|
| Dividend Yield | 1.5% |
| Market Cap | 4B |
| PE Ratio | 24.84 |
| Beta | 0.15 |
Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical excipients and synthetic lubricating base oils to the pharmaceutical companies in China. It is involved in the bio-based material manufacturing, sales, and technology development; technical development and consulting; bio-based material technology research and development; biochemical product technology research and development; food and food additive production and sales; and research and development of new material technologies, as well as provides technical services; and manufactures and sells electronic materials. The company also exports its products to Europe, the United States, Southeast Asia, and internationally. The company was formerly known as Nanjing Well Pharmaceutical Co.,Ltd. and changed its name to Nanjing Well Pharmaceutical Group Co.,Ltd. in April 2020. Nanjing Well Pharmaceutical Group Co.,Ltd. was founded in 2000 and is based in Nanjing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 603351.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
